弥漫性肺疾病的定量CT分析
本文阐述定量CT分析在弥漫性肺疾病临床评估和管理中的作用,包括辅助准确诊断和纵向管理、提高疾病严重度评估的可重复性,并可能作为评估疗效的替代终点。定量CT已应用于阻塞性、浸润性和限制性肺疾病,但训练数据质量、缺乏验证标准及对结局影响的真实世界评估等挑战仍限制其发展。
要点
- 定量CT可提高弥漫性肺疾病严重度评估的可重复性,并辅助诊断与纵向管理。
- 定量疾病严重度指数可能作为评估疗效的有用工具或替代终点。
- 伪影、吸气用力差异、采集重建技术差异及分割不准确可导致分类不准确。
核心结论
- 定量分析正发展成为补充传统视觉评估的可行工具,可为弥漫性肺疾病的诊断、预后和纵向评估提供决策支持。
研究设计与样本
- 本文为综述,探讨定量影像工具在弥漫性肺疾病评估与管理中的作用,未报告检索范围与纳入文献数量。
关键影像表现/征象
- 肺实质特征可通过阈值、直方图、形态学和纹理分析方法进行分类。
- 定量CT分析已应用于肺气肿、囊性纤维化、哮喘、特发性肺纤维化、过敏性肺炎、结缔组织相关间质性肺病及肺纤维化合并肺气肿。
局限性
- 训练数据的质量。
- 缺乏验证结果准确性的标准。
- 缺乏对结局影响的真实世界评估。
- 患者运动或金属束硬化等伪影、吸气用力变化、图像采集和重建技术差异,或解剖结构分割等预处理步骤不准确,可能导致分类不准确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Quantitative analysis of thin-section CT of the chest has a growing role in the clinical evaluation and management of diffuse lung diseases. This heterogeneous group includes diseases with markedly different prognoses and treatment options. Quantitative tools can assist in both accurate diagnosis and longitudinal management by improving characterization and quantification of disease and increasing the reproducibility of disease severity assessment. Furthermore, a quantitative index of disease severity may serve as a useful tool or surrogate endpoint in evaluating treatment efficacy. The authors explore the role of quantitative imaging tools in the evaluation and management of diffuse lung diseases. Lung parenchymal features can be classified with threshold, histogram, morphologic, and texture-analysis-based methods. Quantitative CT analysis has been applied in obstructive, infiltrative, and restrictive pulmonary diseases including emphysema, cystic fibrosis, asthma, idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, connective tissue-related interstitial lung disease, and combined pulmonary fibrosis and emphysema. Some challenges limiting the development and practical application of current quantitative analysis tools include the quality of training data, lack of standard criteria to validate the accuracy of the results, and lack of real-world assessments of the impact on outcomes. Artifacts such as patient motion or metallic beam hardening, variation in inspiratory effort, differences in image acquisition and reconstruction techniques, or inaccurate preprocessing steps such as segmentation of anatomic structures may lead to inaccurate classification. Despite these challenges, as new techniques emerge, quantitative analysis is developing into a viable tool to supplement the traditional visual assessment of diffuse lung diseases and to provide decision support regarding diagnosis, prognosis, and longitudinal evaluation of disease. ©RSNA, 2019.
引用
- Chen A, Karwoski RA, Gierada DS, et al. Quantitative CT Analysis of Diffuse Lung Disease. Radiographics. 2019. PMID: 31782933. doi:10.1148/rg.2020190099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。